Dexcom G6 Pro
Paid
Regulatory Status Disclosed
Overview
The Dexcom G6 Pro is a practice-owned continuous glucose monitoring (CGM) system designed for healthcare providers to gather accurate glucose data from patients. It supports individualized treatment plans for patients with and without diabetes. The system offers both a blinded mode, where real-time glucose data is hidden from the patient and reviewed retrospectively with their healthcare professional, and an unblinded mode, where patients can view their glucose data in real-time on a compatible smart device. The Dexcom G6 Pro is intended to replace fingerstick blood glucose testing for diabetes treatment decisions and can be used by patients aged 2 years and older. It integrates with Dexcom Clarity software for comprehensive reporting and analysis of glucose patterns, trends, and statistics.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Blinded and Unblinded Modes
- Disposable Transmitter
- Real-Time Alerts (Unblinded Mode)
- Factory-Calibrated (Zero Fingersticks Required)
- One-Touch Auto-Applicator
- 10-Day Sensor Wear
- Integration with Dexcom Clarity
- Indicated for patients with or without diabetes (Blinded Mode)
- Indicated for patients with diabetes (Unblinded Mode)
- Acetaminophen interference immunity (standard doses)
Use Cases
- Assessing glycemic variability in patients with or without diabetes
- Diabetes management for patients aged 2 years and older
- Adjusting treatment plans based on glucose insights
- Empowering patients to understand how lifestyle affects glucose levels
- Monitoring glucose trends and patterns over time
- Providing a trial of CGM before committing to a personal system
What Physicians Need to Know
Key Capabilities
The Dexcom G6 Pro is a professional Continuous Glucose Monitoring (CGM) system that offers both blinded and unblinded modes. In unblinded mode, patients can view real-time glucose data and receive alerts every five minutes on a compatible smart device. In blinded mode, healthcare providers can view retrospective glucose data over a 10-day period without the patient having access to the data during the session. It features a one-touch auto-applicator and a single-use, disposable transmitter that auto-starts. The system is factory-calibrated, eliminating the need for fingersticks for calibration. It provides glucose trends, patterns, and statistics, including Time in Range (TIR), time high, and time low.
Clinical Utility
The Dexcom G6 Pro is indicated for the management of diabetes in individuals aged 2 years and older. It can replace fingerstick blood glucose testing for diabetes treatment decisions. It's also used for assessing glycemic variability in patients with or without diabetes (in blinded mode). The system aids in detecting glucose excursions, facilitating care plan adjustments, and supports individualized treatment plans.
Integration Options
The Dexcom G6 Pro integrates with the Dexcom G6 app (for unblinded mode) and Dexcom Clarity software. The Dexcom G6 Pro reader is used by healthcare professionals to verify session start and extract data from the transmitter for upload to Dexcom Clarity for comprehensive reports. Dexcom Clarity is a preferred tool for healthcare providers to support effective diabetes management. The system is also compatible with Glooko, a digital health and connected care platform for diabetes.
Compliance Status
The Dexcom G6 Pro was cleared by the FDA in October 2019. It complies with FCC part 15 and CISPR 11/FCC part 15 for radio frequency emissions. There was a software correction issued in December 2025 for Android US CGM App version 1.15.0 due to a bug that could cause unexpected app termination, potentially leading to missed glucose values, alarms, or alerts. Users were advised to upgrade the app version.
Pricing Model
The Dexcom G6 Pro is a practice-owned CGM system. Healthcare providers can be reimbursed for CGM setup, training, interpretation, and reporting under CPT codes 95250 and 95251. Without insurance, the estimated cash cost for a Dexcom G6 system (which shares components with G6 Pro) could be $450 or more per month, not including a receiver. Savings programs and patient assistance programs are available.
User Experience
The system features a one-touch auto-applicator for simple sensor insertion and a disposable transmitter that auto-starts. In unblinded mode, the Dexcom G6 app offers basic features like glucose data, event entry, high and low alerts, and an Urgent Low alarm. Advanced features like Share/Follow and alert schedules are not supported in the G6 Pro app. Sensors can be worn for up to 10 days.
Support Quality
Dexcom provides training videos and resources for healthcare professionals, including patient handouts. Users have reported instances of sensor failure, requiring contact with technical support for replacements.
Implementation Complexity
The system aims to simplify office workflow. The reader is for office use only and does not display real-time CGM data, but verifies session start and extracts data for Dexcom Clarity. Patients using unblinded mode need a compatible smartphone and may need assistance with app setup and data sharing.
Evidence Base
The Dexcom G6 Pro has an overall Mean Absolute Relative Difference (MARD) of 9% and is considered to have the accuracy of the personal Dexcom G6 CGM system. Real-world studies have shown a MARD of 11.0% over a median of 50 hours, with accuracy improving after the first 12 hours. Clinical trials have substantiated the efficacy of Dexcom CGM systems for insulin-using patients with type 1 or type 2 diabetes, showing significant A1C reduction and increased Time in Range.
Physician Tip
Utilize the dual-mode functionality (blinded for diagnostic assessment, unblinded for patient engagement and real-time feedback) to tailor care. Leverage Dexcom Clarity for comprehensive data analysis and reporting, which can significantly aid in treatment plan adjustments. Educate patients thoroughly on compatible devices and app usage for unblinded mode to ensure optimal data flow and patient satisfaction. Be aware of the reimbursement codes (CPT 95250 and 95251) for professional CGM services.
The Dexcom G6 Pro seamlessly integrates with the Dexcom G6 app for real-time data display in unblinded mode and with Dexcom Clarity for professional data review and reporting. The system also supports integration with third-party platforms like Glooko for broader digital health management. Ensure patients have compatible smart devices for unblinded use and guide them through the Dexcom Clarity sharing process for efficient data access.
Details
| Category | Endocrinology & Metabolic AI, Wearables & Remote Monitoring (RPM) |
| Pricing |
Paid
|
| Deployment | On-premise (practice-owned system with patient-worn sensor/transmitter) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
Cleared AI-estimated The Dexcom G6 Pro Continuous Glucose Monitoring System received FDA clearance on October 8, 2019, for healthcare professionals to use with patients aged two years and up. |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Family Medicine, Internal Medicine |
What the Web Says
The Dexcom G6 Pro is a continuous glucose monitoring (CGM) system that provides real-time glucose readings without the need for regular fingerstick calibrations. It's praised by physicians and users for its accuracy, ease of use, and ability to provide a comprehensive picture of glucose trends, which can help in managing diabetes and preventing health crises. The system offers direct-to-mobile app connectivity and can integrate with insulin pumps.
Overall: PositiveStrengths
- Eliminates the need for most fingerstick calibrations, offering real-time, continuous glucose readings.
- Easy and pain-free sensor insertion with a one-button applicator.
- Sensors can be worn for 10 days, an improvement over earlier models.
- Provides customizable alerts for high, low, rising, or dropping blood sugar, including a predictive urgent low glucose alert.
- Data sharing feature allows real-time glucose levels to be shared with up to 10 people.
- Water-resistant design allows for wear during showers, baths, and swimming.
Limitations
- Sensors and transmitters may fail prematurely, not lasting the full advertised duration.
- Customer service and issues with insurance claims and deliveries are common complaints.
- The adhesive may not last the full 10 days, requiring additional patches.
- The system generates a significant amount of single-use plastic waste.
- Some users report initial inaccuracies in readings during the first few hours after sensor application.
- The app may not be officially supported on newer phone models, requiring workarounds.
Based on reviews from: Healthline, diaTribe.org, Reddit, YouTube, Apple App Store, Hugging the Cactus, Medical News Today, Aptiva Medical, Medium, Dexcom
Last updated: 2026-07-27
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Dexcom G6 Pro
Press & Coverage
Business Wire (via Dexcom Investor Relations)
Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM
Dexcom announced FDA clearance for its G6 Pro Continuous Glucose Monitoring (CGM) System for healthcare professionals to use with patients aged two years and up. It is the first and only single-use professional CGM offering both blinded and unblinded modes for 10-day glucose data collection.
2019-10
Medical Economics
FDA approves first single-use continuous glucose monitoring system - Medical Economics
The FDA approved the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for physicians to monitor patient data in real time. This system is the first and only single-use CGM that collects real-time glucose data over a 10-day period in both blinded and unblinded modes.
2019-10
Drug Topics
Dexcom G6 Continuous Glucose Monitor Approved by FDA | Drug Topics
Dexcom's G6 Pro continuous glucose monitoring system received FDA approval for healthcare professionals to use with patients aged two years and older. The new CGM eliminates fingersticks for calibration and offers both blinded and unblinded data presentation modes.
2019-10
BioSpace
Dexcom Receives FDA Clearance for Dexcom G6 Pro Continuous Glucose Monitor
Dexcom announced FDA clearance for its G6 Pro Continuous Glucose Monitoring (CGM) System, designed for healthcare professionals to use with patients two years and older. The system can collect real-time glucose data over 10 days and features both blinded and unblinded modes.
2019-10
Healio
FDA clears Dexcom G6 Professional CGM System - Healio
The FDA approved Dexcom's G6 Pro CGM System, a professional continuous glucose monitoring system that tracks glucose measures for 10 days. It offers both blinded and unblinded modes, allowing patients to either review data retrospectively with a physician or access it in real-time.
2019-10
Eli Lilly and Company (via PR Newswire)
Lilly and Dexcom team up on new program to help improve diabetes management
Eli Lilly and Dexcom announced a joint program for healthcare providers to promote Lilly's rapid-acting insulin, Lyumjev, with Dexcom G6 and G6 Pro CGM Systems. The program aims to help clinicians use CGM data to inform diabetes management and identify patients who may benefit from Lyumjev.
2020-10
Diabetes Technology & Therapeutics (via PMC)
Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial - PMC
A study evaluated the real-world accuracy of the blinded Dexcom G6 Pro sensor during the Insulin-Only Bionic Pancreas Trial, finding a mean absolute relative difference (MARD) of 11.0% over a median of 50 hours. Accuracy improved after the first 12 hours and remained stable.
2023-11
Diabetes Technology & Therapeutics (via PMC)
Accuracy of Dexcom G6 Pro and G7 Continuous Glucose Monitors in Patients Treated with Maintenance Dialysis - PMC
This study assessed the accuracy of Dexcom G6 Pro and G7 CGMs in patients with diabetes undergoing maintenance dialysis. It found Pearson correlation coefficients of 0.87 and 0.88, and MARDs of 21.2% and 16.7% respectively, compared to SMBG, with most values in clinically acceptable zones.
2026-02
Videos
Product demos, reviews, and walkthroughs for Dexcom G6 Pro.
Dexcom G6 Pro - Amazing Continuous Glucose Monitor - MedMinute
Medical Specialty Clinic
Dexcom G6 u2014 How To Get Started with your Receiver
Dexcom
Dexcom G6 u2014 How To Insert the Sensor and Attach the Transmitter
Dexcom
Dexcom G6 Pro u2014 Getting Started with the Dexcom G6 App
Dexcom
Dexcom G6 Setup | Watch Before You Get Started
Type One Talks
Last Dexcom G6 Swap #diabetes #t1d #dexcom #dexcomchange #dexcomg6 #expressionmed @ExpressionMed
Clinton Svatos
Frequently Asked Questions
The Dexcom G6 Pro provides data that can be manually uploaded or integrated with compatible software. While it doesn't have direct, real-time AI integration built-in, its data can be exported and then imported into various healthcare AI platforms or EHRs for retrospective analysis, trend identification, and population health management. This allows for leveraging AI tools to derive deeper insights from the continuous glucose monitoring data.
The Dexcom G6 Pro, as a medical device, adheres to relevant regulatory standards such as FDA clearance in the US and CE Mark in Europe. Data privacy compliance, including HIPAA and GDPR, is primarily the responsibility of the healthcare provider when handling and storing patient data obtained from the device. Dexcom provides secure data transmission and storage within its ecosystem, but providers must ensure their own practices align with these regulations.
While the Dexcom G6 Pro provides highly accurate real-time glucose data, several emerging AI-powered solutions and platforms are integrating CGM data with other health metrics to offer more advanced predictive analytics and personalized treatment recommendations. These often involve third-party software or integrated insulin pump systems that utilize AI algorithms to anticipate glucose trends and suggest insulin adjustments, going beyond the G6 Pro's primary function of glucose monitoring.
The pricing structure for the Dexcom G6 Pro typically involves the cost of the transmitter and individual sensors. Specific pricing for healthcare providers, including potential subscription models or bulk purchasing discounts, can vary and are usually negotiated directly with Dexcom or authorized distributors. It's recommended to contact a Dexcom representative for detailed and current pricing information tailored to your practice's needs.
The Dexcom G6 Pro is highly accurate, but like all CGM systems, it has limitations. Sensor lifespan is fixed at 10 days, and while rare, factors like acetaminophen can temporarily affect readings. Potential interference with certain medical procedures (e.g., MRI, CT scans, diathermy) exists, and patients should be advised to remove the sensor before such procedures. It's crucial to understand these limitations for appropriate patient selection and interpretation of data.
The Dexcom G6 Pro facilitates remote patient monitoring by allowing patients to share their glucose data with healthcare providers in real-time through the Dexcom CLARITY app. This data can then be accessed remotely by clinicians, enabling timely interventions and adjustments to treatment plans. While the G6 Pro itself doesn't provide AI-driven insights directly, the continuous data stream is a foundational component for telehealth platforms that integrate AI to analyze trends and support clinical decision-making for chronic conditions.
Dexcom provides comprehensive training and support resources for healthcare professionals, including online modules, educational materials, and clinical support teams. These resources cover device application, data interpretation, and integration into clinical workflows. While specific training on AI-enhanced care pathways might be provided by third-party AI solution providers, Dexcom's support ensures clinicians are proficient in using the G6 Pro to generate the foundational data for such advanced applications.
Suggest an Edit →
| Last Verified: 2026-07-26 | First Added: 2026-07-26
Investors who backed Dexcom G6 Pro
Funded through the company that built this tool.
